Application of calcium phosphate as a controlled-release device
- PMID: 24189411
- DOI: 10.1248/bpb.b13-00383
Application of calcium phosphate as a controlled-release device
Abstract
Calcium phosphate (CaP)-based compounds are biocompatible and have been accepted as promising candidates for novel drug-releasing devices. CaP is biodegradable and can be utilized as a durable drug release reservoir. We developed an injectable self-setting apatite cement. When a plasmid DNA complex containing CaP was injected into tumor-bearing mice, it solidified in the body and slowly released the DNA complex, inducing durable gene expression and high therapeutic effect on solid tumors. Encapsulation of a drug by CaP acts as a protective capsule for the unstable contents and improves biocompatibility. CaP nanocapsules encapsulating a plasmid DNA complex or drug-involved micelle were prepared, and they showed high stability against enzyme and protein degradation. CaP also showed high potential as a durable acid pH buffer. Aqueous alginate solution was found to form a soft gel in the body and was investigated as a drug-releasing device. However, degradation of the alginate gel is sometimes too rapid in an acidic environment such as the area around osteoporotic bones. We found that amorphous CaP powder added to the alginate gel could control the dissociation rate, buffering the pH inside the gel. Alginate gel including CaP powder and a drug for osteoporosis allowed sustained release of the drug under acidic conditions, and a good therapeutic effect was achieved in osteoporosis model rats. CaP could thus be a valuable material for drug-delivery systems as a slow-releasing drug reservoir, a protective coating, or a pH buffer.
Similar articles
-
Preparation of injectable auto-forming alginate gel containing simvastatin with amorphous calcium phosphate as a controlled release medium and their therapeutic effect in osteoporosis model rat.J Mater Sci Mater Med. 2012 May;23(5):1291-7. doi: 10.1007/s10856-012-4597-3. Epub 2012 Mar 4. J Mater Sci Mater Med. 2012. PMID: 22391994
-
Preparation of calcium phosphate nanocapsules including simvastatin/deoxycholic acid assembly, and their therapeutic effect in osteoporosis model mice.J Pharm Pharmacol. 2013 Apr;65(4):494-502. doi: 10.1111/jphp.12008. Epub 2012 Nov 22. J Pharm Pharmacol. 2013. PMID: 23488777
-
Preparation of calcium phosphate nanocapsule including deoxyribonucleic acid-polyethyleneimine-hyaluronic acid ternary complex for durable gene delivery.J Pharm Sci. 2014 Jan;103(1):179-84. doi: 10.1002/jps.23768. Epub 2013 Nov 1. J Pharm Sci. 2014. PMID: 24186653
-
Incorporation of chitosan-alginate complex into injectable calcium phosphate cement system as a bone graft material.Mater Sci Eng C Mater Biol Appl. 2019 Jan 1;94:385-392. doi: 10.1016/j.msec.2018.09.039. Epub 2018 Sep 19. Mater Sci Eng C Mater Biol Appl. 2019. PMID: 30423721
-
Recent advances of calcium phosphate nanoparticles for controlled drug delivery.Mini Rev Med Chem. 2013 Aug;13(10):1501-7. doi: 10.2174/13895575113139990059. Mini Rev Med Chem. 2013. PMID: 22697516 Review.
Cited by
-
Hydrogel-based delivery system applied in the local anti-osteoporotic bone defects.Front Bioeng Biotechnol. 2022 Nov 11;10:1058300. doi: 10.3389/fbioe.2022.1058300. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36440439 Free PMC article. Review.
-
pH-dependent sedimentation of DNA in the presence of divalent, but not monovalent, metal ions.Anal Biochem. 2021 Mar 1;616:114099. doi: 10.1016/j.ab.2020.114099. Epub 2020 Dec 31. Anal Biochem. 2021. PMID: 33388294 Free PMC article.
-
Inorganic phosphate in the development and treatment of cancer: A Janus Bifrons?World J Clin Oncol. 2015 Dec 10;6(6):198-201. doi: 10.5306/wjco.v6.i6.198. World J Clin Oncol. 2015. PMID: 26677430 Free PMC article.
-
Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells.Molecules. 2015 Sep 1;20(9):15910-28. doi: 10.3390/molecules200915910. Molecules. 2015. PMID: 26340617 Free PMC article.
-
Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media.Curr Allergy Asthma Rep. 2015 Apr;15(4):14. doi: 10.1007/s11882-015-0517-1. Curr Allergy Asthma Rep. 2015. PMID: 26130474 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
